Search - tctmd.com

Displaying 701 - 720 of 2145

Sort: Relevancy | Date

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

June 19, 2019

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

June 18, 2019

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

News Daily News

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Yael L. Maxwell

June 18, 2019

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

News Daily News

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

June 17, 2019

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

June 10, 2019

Terumo’s Solopath Transfemoral System and Recollapsible Balloon Access System Recalled for Dislodging Issues

News Daily News

Terumo’s Solopath Transfemoral System and Recollapsible Balloon Access System Recalled for Dislodging Issues

May 30, 2019

OVER Trial: Long-term Mortality Similar After Endovascular and Open AAA Repair

News Daily News

OVER Trial: Long-term Mortality Similar After Endovascular and Open AAA Repair

May 30, 2019

FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting

News Daily News

FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting

May 21, 2019

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

May 14, 2019

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

May 09, 2019

Device-Related Thrombus and LAA Closure: Rare but Dangerous

News Daily News

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Yael L. Maxwell

May 09, 2019

FDA Warns of Premature Battery Depletion With Certain Medtronic Pacemakers

News Daily News

FDA Warns of Premature Battery Depletion With Certain Medtronic Pacemakers

Michael O'Riordan

May 07, 2019

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

May 06, 2019

Mortality From Heart Failure Increasing in United States

News Daily News

Mortality From Heart Failure Increasing in United States

Michael O'Riordan

May 06, 2019

AHA Advisory Emphasizes Need for Food-System Innovation, and Proof That It Works

News Daily News

AHA Advisory Emphasizes Need for Food-System Innovation, and Proof That It Works

Yael L. Maxwell

May 02, 2019

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

May 01, 2019

TCTMD’s Top 10 Most Popular Stories for April 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

May 01, 2019

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.